A Phase II LYSA Study of Obinutuzumab Combined with Lenalidomide for Relapsed or Refractory Aggressive B-Cell Lymphoma

Affiliation auteurs!!!! Error affiliation !!!!
TitreA Phase II LYSA Study of Obinutuzumab Combined with Lenalidomide for Relapsed or Refractory Aggressive B-Cell Lymphoma
Type de publicationJournal Article
Year of Publication2016
AuteursMorschhauser F, Cartron G, Salles GA, Bijou F, Fruchart C, Bouabdallah K, Feugier P, Le Gouill S, Tilly H, Molucon-Chabrot C, Maerevoet M, Casasnovas R-O, Van den Neste EW, Zachee P, Van Eygen K, Van Hoof A, Bonnet C, Haioun C, Andre M, Xerri L, Houot R
JournalBLOOD
Volume128
Date PublishedDEC 2
Type of ArticleMeeting Abstract
ISSN0006-4971
DOI10.1182/blood.V128.22.4202.4202